Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Targeting microRNAs to modulate neutrophil trafficking and improve resolution of gut inflammation.

Award Number: R21AI187459
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/04/2025
PERIOD OF PERFORMANCE END DATE: 08/31/2027

Group Awards By:

View Award Description

Targeting microRNAs to modulate neutrophil trafficking and improve resolution of gut inflammation. - Neutrophil activity in tissues can exacerbate inflammation and promote tissue damage, as seen in inflammatory bowel diseases (IBD). Thus, studies focused on PMN trafficking are of continued interest and physiological significance. Crossing of the endothelial cell (EC) barrier is the first critical regulatory step in tissue PMN effector function and targeting existing and novel signaling molecules/pathways involved in this process is an attractive therapeutic strategy. miRNAs-focused therapies are an exciting emerging field, with several miRNA therapeutics already approved for clinical use and more being tested in clinical trials. Identification of miRNAs has been acknowledged by the 2024 Nobel Prize in Medicine, highlighting their significant impact and potential as therapeutics. As such miRNAs present an exciting opportunity for therapies, as their expression can be easily manipulated using synthetic miRNA mimics or antagonists, which can be synthesized as cell permeable molecules with superior tissue uptake. miRNAs broadly regulate many biological processes and have been implicated in IBD pathogenesis and heightened immune response. Specifically, miRNAs can regulate organization of the actin cytoskeleton, cell polarity, cytokine/chemokine signaling and cell adhesion, all of which are critical regulatory process of neutrophil transendothelial migration (TEM).Thus, in the current studies we propose to perform an unbiased miRNA profiling in circulating PMNs in clinically relevant infectious, salmonella- induced and DSS-induced colitis/injury models followed by phenotypical and functional target validation with the goal of 1. Identifying novel microRNAs that regulate PMN TEM in gut inflammation and 2. Establishing whether manipulating miRNA activity can effectively suppress PMN TEM and improve resolution of gut inflammation. In preliminary work we established the premise for targeting reduction in neutrophil migration and tissue accumulation to improve disease outcomes in these models. We also optimized all relevant protocols for blood neutrophil isolation and mRNA sequencing. These high-risk-high-reward studies are well suited for the R21 funding mechanism as they provide a platform for the development of novel interventions, such as miRNA therapeutics, aimed at regulation of PMN crossing of the vascular wall and trafficking into tissue, which will help achieve important clinical endpoints, including resolution of mucosal inflammation and wound healing.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $200,000 )
2025	2025	NORTHWESTERN UNIVERSITY	633 CLARK ST	EVANSTON	IL	60208	COOK	USA	Allergy and Infectious Diseases Research	000	1	9/4/2025	NEW	$200,000
														Subtotal = $200,000

Grand Total All Awards = $200,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Targeting microRNAs to modulate neutrophil trafficking and improve resolution of gut inflammation.

Award Number: R21AI187459

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/04/2025

PERIOD OF PERFORMANCE END DATE: 08/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer